Sparing of extraocular muscle in aging and muscular dystrophies: A myogenic precursor cell hypothesis

Experimental Cell Research

Volumn 317, Issue 6, 2011, Pages 873-885

  Kallestad, Kristen M ^a   Hebert, Sadie L ^a   McDonald, Abby A ^a   Daniel, Mark L ^a   Cu, Sharon R ^a   McLoon, Linda K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aging; CD34; Extraocular muscles; Flow cytometry; Muscular dystrophy; Myogenic precursor cells; Satellite cells

Indexed keywords

ATAXIN 1; CADHERIN; CD31 ANTIGEN; CD34 ANTIBODY; CD45 ANTIGEN;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EXTRAOCULAR MUSCLE; FLOW CYTOMETRY; IN VITRO STUDY; MONONUCLEAR CELL; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

MUS;

EID: 79952189281     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.01.018     Document Type: Article

References (69)

1. Wallace G.Q., McNally E.M. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu. Rev. Physiol. 2009, 71:37-57.
2. Rando T.A. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve. 2001, 24:1575-1594.
3. Manzur A.Y., Muntoni F. Diagnosis and new treatments in muscular dystrophies. J. Neurol. Neurosurg. Psychiatry 2009, 80:706-714.
4. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., Rando T.A. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810.
5. Taylor-Jones J.M., McGehee R.E., Rando T.A., Lecka-Czernik B., Lipschitz D.A., Peterson C.A. Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev. 2002, 123:649-661.
6. Gussoni E., Pavlath G.K., Lanctot A.M., Sharma K.R., Miller R.G., Steinman L., Blau H.M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992, 356:435-438.
7. Miller R.G., Sharma K.R., Pavlath G.K., Gussoni E., Mynhier M., Lanctot A.M., Greco C.M., Steinman L., Blau H.M. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 1997, 20:469-478.
8. Pavlath G.K., Rando T.A., Blau H.M. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell Biol. 1994, 127:1923-1932.
9. Tremblay J.P., Bouchard J.P., Malouin F., Theau D., Cottrell F., Collin H., Rouche A., Gilgenkrantz S., Abbadi N., Tremblay M., Tome F., Fardeau M. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul. Disord. 1993, 3:583-592.
10. Hong F., Lee J., Song J.W., Lee S.J., Ahn H., Cho J.J., Ha J., Kim S.S. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J. 2002, 16:1633-1635.
11. Karpati G., Ajdukovic D., Arnold D., Gledhill R.B., Guttmann R., Holland P., Koch P.A., Shoubridge E., Spence D., Vanasse M., Walters G.V., Abrahamowicz M., Duff C., Worton R.G. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 1993, 34:8-17.
12. Kinoshita I., Vilquin J.T., Guerette B., Asselin I., Roy R., Tremblay J.P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994, 17:1407-1415.
13. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., Morgan J.E. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005, 122:289-301.
14. Seale P., Sabourin L.A., Girgis-Gabardo A., Mansouri A., Gruss P., Rudnicki M.A. Pax7 is required for the specification of myogenic satellite cells. Cell 2000, 102:777-786.
15. Beauchamp J.R., Heslop L., Yu D.S., Tajbakhsh S., Kelly R.G., Wernig A., Buckingham M.E., Partridge T.A., Zammit P.S. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell Biol. 2000, 151:1221-1234.
16. Cornelison D.D., Filla M.S., Stanley H.M., Rapraeger A.C., Olwin B.B. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 2001, 239:79-94.
17. Allen R.E., Sheehan S.M., Taylor R.G., Kendall T.L., Rice G.M. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J. Cell Physiol. 1995, 165:307-312.
18. Fukada S., Higuchi S., Segawa M., Koda K., Yamamoto Y., Tsujikawa K., Kohama Y., Uezumi A., Imamura M., Miyagoe-Suzuki Y., Takeda S., Yamamoto H. Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp. Cell Res. 2004, 296:245-255.
19. Ono Y., Boldrin L., Knopp P., Morgan J.E., Zammit P.E. Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev. Biol. 2010, 337:29-41.
20. Rossi C.A., Pozzobon M., Ditadi A., Archacka K., Gastaldello A., Sanna M., Franzin C., Malerba A., Milan G., Cananzi M., Schiaffino S., Campella M., Vettor R., De Coppi P. Clonal characterization of rat muscle satellite cells: proliferation, metabolism and differentiation define an intrinsic heterogeneity. PloS One 2010, 5:e8523.
21. Montarras D., Morgan J., Collins C., Relaix F., Zaffran S., Cumano A., Partridge T., Buckingham M. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005, 309:2064-2067.
22. Lindström M., Thornell L.E. New multiple labelling method for improved satellite cell identification in human muscle: application to a cohort of power-lifters and sedentary men. Histochem Cell Biol. 2009, 132:141-157.
23. Karpati G., Carpenter S. Small caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am. J. Med. Genet. 1986, 25:653-658.
24. Kaminski H.J., al-Hakim M., Leigh R.J., Katirji M.B., Ruff R.L. Extraocular muscles are spared in advanced Duchenne dystrophy. Ann. Neurol. 1992, 32:586-588.
25. Andrade F.H., Porter J.D., Kaminski H.J. Eye muscle sparing by the muscular dystrophies: lessons to be learned? Microsc. Res. Techn. 2000, 48:192-203.
26. Porter J.D., Karathanasis P. Extraocular muscle in merosin-deficient muscular dystrophy: cation homeostasis is maintained but is not mechanistic in muscle sparing. Cell Tissue Res. 1998, 292:495-501.
27. Porter J.D., Merriam A.P., Hack A.A., Andrade F.H., McNally E.M. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. Neuromuscul. Disord. 2001, 11:197-207.
28. Mendell J.R., Sahenk Z., Prior T.W. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane stability. J. Child Neurol. 1995, 10:150-159.
29. McLoon L.K., Wirtschafter J. Activated satellite cells in extraocular muscles of normal adult monkeys and humans. Invest. Ophthalmol. Vis. Sci. 2003, 44:1927-1932.
30. McMullen C.A., Ferry A.L., Gamboa J.L., Andrade F.H., Dupont-Versteegden E.E. Age-related changes of cell death pathways in rat extraocular muscle. Exp. Gerontol. 2009, 44:420-425.
31. Khurana T.S., Prendergast R.A., Alameddine H.S., Tome F.M., Fardeau M., Arahata J., Sugita H., Kunkel L.M. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J. Exp. Med. 1995, 182:467-475.
32. Porter J.D., Merriam A.P., Khanna S., Andrade A.H., Richmonds C.R., Leahy P., Cheng G., Karathanasis P., Zhou X., Kusner L.L., Adams M.E., Willem M., Mayer U., Kaminski H.J. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J. 2003, 17:893-895.
33. Ragusa R.J., Chow C.K., Porter J.D. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul. Disord. 1997, 7:379-386.
34. Wehling M., Stull J.T., McCabe T.J., Tidball J.G. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase. Neuromuscul. Disord. 1998, 8:22-29.
35. Zhou L., Porter J.D., Cheng G., Gong B., Hatala D.A., Merriam A.P., Zhou X., Rafael J.A., Kaminski H.J. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul. Disord. 2006, 16:32-38.
36. McLoon L.K., Wirtschafter J.D. Continuous myonuclear addition to single extraocular myofibers in uninjured adult rabbits. Muscle Nerve 2002, 25:348-358.
37. McLoon L.K., Wirtschafter J.D. Activated satellite cells are present in uninjured extraocular muscles of mature mice. Trans. Am. Ophthalmol. Soc. 2002, 100:119-123.
38. McLoon L.K., Rowe J., Wirtschafter J., McCormick K.M. Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis. Muscle Nerve 2004, 29:707-715.
39. Tajbakhsh S., Rocancourt D., Cossu G., Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5ac upstream of MyoD. Cell 1997, 89:127-138.
40. Diehl A.G., Zareparsi S., Qian M., Khanna R., Angeles R., Gage P.J. Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. Invest Ophthalmol Vis Sci. 2006, 47:1785-1793.
41. Ugalde I., Christiansen S.P., McLoon L.K. Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodeling. Invest. Ophthalmol. Vis. Sci. 2005, 46:4114-4120.
42. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738.
43. Asakura A., Komaki M., Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.
44. Kallestad K.M., McLoon L.K. Defining the heterogeneity of skeletal muscle-derived side and main population cells isolated immediately ex vivo. J. Cell. Physiol. 2010, 222:676-684.
45. Gharaibeh B., Lu A., Tebbets J., Zheng B., Feduska J., Crisan M., Peault B., Cummins J., Huard J. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat. Protoc. 2008, 3:1501-1509.
46. Wieczorek D.F., Periasamy M., Butler-Browne G.S., Whalen R.G., Nadal-Ginard B. Co-expression of multiple myosin heavy chain genes, in addition to a tissue-specific one, in extraocular musculature. J Cell Biol. 1985, 101:618-629.
47. Horton R.M., Manfredi A.A., Conti-Tronconi B.M. The embryonic gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurology 1993, 43:983-986.
48. McLoon L.K., Wirtschafter J.D. N-CAM is expressed in mature extraocular muscles in a pattern conserved among three species. Invest. Ophthalmol. Vis. Sci. 1996, 37:318-327.
49. Anderson B.C., Christiansen S.P., Grandt S., Grange R.W., McLoon L.K. Increased extraocular muscle strength with direct injection of insulin-like growth factor-1. Invest. Ophthalmol. Vis. Sci. 2006, 47:2461-2467.
50. Shinners M.J., Goding G.S., McLoon L.K. Effect of recurrent laryngeal nerve section on the laryngeal muscles of adult rabbits. Otolaryngol. Head Neck Surg. 2006, 134:413-418.
51. McLoon L.K., Thorstenson K.M., Solomon A., Lewis M.P. Myogenic precursor cells in craniofacial muscles. Oral Dis. 2007, 13:134-140.
52. Wozniak A.C., Pilipowicz O., Yablonka-Reuveni Z., Greenway S., Craven S., Scott E., Anderson J.E. C-Met expression and mechanical activation of satellite cells on cultured muscle fibers. J. Histochem. Cytochem. 2003, 51:1437-1445.
53. Zammit P.S., Heslop L., Hudon V., Rosenblatt J.D., Tajbakhsh S., Buckingham M.E., Beauchamp J.R., Partridge T.A. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp. Cell Res. 2002, 281:39-49.
54. Renault V., Piron-Hamelin G., Forestier C., DiDonna S., Decary S., Hentati F., Saillant G., Butler-Browne G.S., Mouly V. Skeletal muscle regeneration and the mitotic clock. Exp. Gerontol. 2000, 35:711-719.
55. Decary S., Hamida C.B., Mouly V., Barbet J.P., Hentati F., Butler-Browne G.S. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 2000, 10:113-120.
56. Mouly V., Aamiri A., Bigot A., Cooper R.N., Di Donna S., Furling D., Gidaro T., Jacquemin V., Manchaoui K., Negroni E., Perie S., Renault V., Silva-Barbosa S.S., Butler-Browne G.S. The mitotic clock in skeletal muscle regeneration, disease and cell medicated gene therapy. Acta Physiol. Scand. 2005, 184:3-15.
57. Shea K.L., Xiang W., LaPorta V.S., Licht J.D., Keller C., Basson M.A., Brack A.S. Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration. Cell Stem Cell. 2010, 6:117-129.
58. Smith C.K., Janney M.J., Allen R.E. Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J. Cell Physiol. 1994, 159:379-385.
59. Sacco A., Doyonnas R., Kraft P., Vitorovic S., Blau H.M. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008, 456:502-506.
60. Kuang S., Gillespie M.A., Rudnicki M.A. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008, 2:22-31.
61. Ten Broek R.W., Grefte S., Von den Hoff J.W. Regulatory factors and cell populations involved in skeletal muscle regeneration. J Cellul Physiol. 2010, 224:7-16.
62. Asakura A., Hirai H., Kablar B., Morita S., Ishibashi J., Piras B.A., Christ A.J., Verma M., Vineretsky K.A., Rudnicki M.A. Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regeneration skeletal muscle. Proc. Natl. Acad. Sci. USA 2007, 104:16552-16557.
63. Rudnicki M.A., Le Grand F., McKinnell I., Kuang S. The molecular regulation of muscle stem cell function. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:323-331.
64. Spencer R.F., McNeer K.W. Botulinum toxin paralysis of adult monkey extraocular muscle. Structural alterations in orbital, singly innervated muscle fibers. Arch. Ophthalmol. 1987, 105:1703-1711.
65. Porter J.D., Edney D.P., McMahon E.J., Burns L.A. Extraocular myotoxicity of the retrobulbar anesthetic bupivacaine hydrochloride. Invest. Ophthalmol. Vis. Sci. 1988, 29:163-174.
66. Chen Y.W., Nagaraju K., Bakay M., McIntyre O., Rawat R., Shi R., Hoffman E.P. Early onset of inflammation and later involvement of TGFb in Duchenne muscular dystrophy. Neurology 2005, 65:826-834.
67. Demoule A., Divangahi M., Danialou G., Gvozdic D., Larkin G., Bao W., Petrof B.J. Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm. Am. J. Respir. Cell Mol. Biol. 2005, 33:178-185.
68. Tidball J.G., Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J. Appl. Physiol. 2007, 102:1677-1686.
69. Darabi R., Perlingeiro R.C. Lineage-specific reprogramming as a strategy for cell therapy. Cell Cycle 2008, 7:1732-1737.